A suggested positive control is A-20 cell lysate.
PA5-20390 can be used with blocking peptide PEP-0507.
Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by Natural IFN-producing cells (IPCs) as part of the host immune response. IFNs can also inhibit the development of tumors. IFN-beta binding results in the activation of the tyrosine kinases Jak1 and Tyk2, phosphorylation of members of the STAT family of transcription factors, and the transcription and expression of the immune response genes. More recently, several members of the toll-like receptor (TLR) family were found to stimulate the production IFN-beta. IFN-beta is currently used clinically for treatment of tumors, infections and multiple sclerosis.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: Fibroblast interferon; IFN-beta; Interferon beta; interferon, beta 1, fibroblast; interferon-beta; RP11-113D19.1, IFB, IFF, IFNB
Gene Aliases: IFB; IFF; IFN-beta; IFNB; IFNB1